Literature DB >> 11359451

Activation of epithelial and myoepithelial cells in the salivary glands of patients with Sjögren's syndrome: high expression of intercellular adhesion molecule-1 (ICAM.1) in biopsy specimens and cultured cells.

E K Kapsogeorgou1, I D Dimitriou, R F Abu-Helu, H M Moutsopoulos, M N Manoussakis.   

Abstract

ICAM.1 (CD54) is a surface protein expressed on epithelial and other nonhematopoietic cells upon activation and is known to play an important role in the stimulation of T cells by the provision of cellular adhesion and costimulatory support. Sjogren's syndrome (SS) is an autoimmune exocrinopathy, which is characterized by chronic lymphocytic infiltration of exocrine glands and aberrant activation of epithelial tissues. To address the contribution of ICAM.1 in the pathogenesis of SS, the expression of this protein was studied by immunohistochemistry and flow cytometry in minor salivary gland (SG) biopsies as well as in cultured SG epithelial cell (SGEC) lines obtained from 18 SS patients and 16 controls. In biopsies from SS patients (but not controls), strong ICAM.1 was expressed by infiltrating mononuclear cells (52%) and by a significant proportion of periacinar myoepithelial cells (18%). In addition, a patchy pattern of moderate ICAM.1 expression was detected in 31% of ductal epithelia of SS patients. These ICAM.1-expressing epithelial and myoepithelial cells were observed throughout glandular tissues and were not confined in areas proximal to lymphoid infiltrates. In support to an intrinsic activation profile of SGEC in SS, long-term cultured non-neoplastic SGEC lines derived from SS patients displayed significantly upregulated spontaneous expression of ICAM.1, compared to controls (P < 0.05). The high expression of ICAM.1 protein by the salivary epithelium of SS patients is likely suggestive of its important role in the pathogenesis of the disorder. Further, our results support a model of intrinsic activation of salivary epithelial and myoepithelial cells in SS, whereby these cells actively participate in the induction and maintenance of lymphocytic infiltrates of patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11359451      PMCID: PMC1906035          DOI: 10.1046/j.1365-2249.2001.01500.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

Review 1.  Membrane stretch and salivary glands - facts and theories.

Authors:  T Zelles; I Boros; G Varga
Journal:  Arch Oral Biol       Date:  1999-05       Impact factor: 2.633

Review 2.  Sjögren's syndrome: autoimmune epithelitis.

Authors:  H M Moutsopoulos
Journal:  Clin Immunol Immunopathol       Date:  1994-08

3.  Thomsen-Friedenreich (T) antigen as marker of myoepithelial and basal cells in the parotid gland, pleomorphic adenomas and adenoid cystic carcinomas. An immunohistological comparison between T and sialosyl-T antigens, alpha-smooth muscle actin and cytokeratin 14.

Authors:  M H Therkildsen; U Mandel; M Christensen; E Dabelsteen
Journal:  APMIS       Date:  1995 Jul-Aug       Impact factor: 3.205

4.  Proinflammatory cytokines and endotoxin stimulate ICAM-1 gene expression and secretion by normal human hepatocytes.

Authors:  S Satoh; A K Nüssler; Z Z Liu; A W Thomson
Journal:  Immunology       Date:  1994-08       Impact factor: 7.397

5.  Investigation of activation markers demonstrates significant overexpression of the secretory component on salivary glands epithelial cells in Sjögren's syndrome.

Authors:  J El Kaissouni; M C Bene; G C Faure
Journal:  Clin Immunol Immunopathol       Date:  1996-06

6.  Expression of cell adhesion molecules in the salivary and lacrimal glands of Sjogren's syndrome.

Authors:  I Saito; K Terauchi; M Shimuta; S Nishiimura; K Yoshino; T Takeuchi; K Tsubota; N Miyasaka
Journal:  J Clin Lab Anal       Date:  1993       Impact factor: 2.352

7.  Cytokine and adhesion molecule expression in the minor salivary glands of patients with Sjögren's syndrome and chronic sialoadenitis.

Authors:  A Cauli; G Yanni; C Pitzalis; S Challacombe; G S Panayi
Journal:  Ann Rheum Dis       Date:  1995-03       Impact factor: 19.103

8.  Modulation of adhesion molecule expression on endothelial cells by verapamil and other Ca++ channel blockers.

Authors:  N P Hailer; R A Blaheta; S Harder; M Scholz; A Encke; B H Markus
Journal:  Immunobiology       Date:  1994-08       Impact factor: 3.144

9.  Secretory component (polymeric immunoglobulin receptor) as an intrinsic inhibitor of biological functions of interferon gamma in keratinocytes.

Authors:  Y Nihei; K Maruyama; J Z Zhang; K Kobayashi; F Kaneko
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

10.  An immunohistochemical study of immunological phenomena in minor salivary glands in patients with Sjögren's syndrome.

Authors:  A Caretto; P A Ostuni; F Chieco-Bianchi; B Pedini; A C Spadaccino; M Bagnasco; S Todesco; C Betterle
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

View more
  28 in total

1.  Downstream activation of NF-κB in the EDA-A1/EDAR signalling in Sjögren's syndrome and its regulation by the ubiquitin-editing enzyme A20.

Authors:  M Sisto; A Barca; D D Lofrumento; S Lisi
Journal:  Clin Exp Immunol       Date:  2016-02-23       Impact factor: 4.330

2.  Expression of functional Toll-like receptors by salivary gland epithelial cells: increased mRNA expression in cells derived from patients with primary Sjögren's syndrome.

Authors:  M P Spachidou; E Bourazopoulou; C I Maratheftis; E K Kapsogeorgou; H M Moutsopoulos; A G Tzioufas; M N Manoussakis
Journal:  Clin Exp Immunol       Date:  2007-03       Impact factor: 4.330

Review 3.  T lymphocytes in Sjögren's syndrome: contributors to and regulators of pathophysiology.

Authors:  Gikas E Katsifis; Niki M Moutsopoulos; Sharon M Wahl
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

4.  Rituximab-mediated Raf kinase inhibitor protein induction modulates NF-κB in Sjögren syndrome.

Authors:  Margherita Sisto; Sabrina Lisi; Massimo D'Amore; Dario D Lofrumento
Journal:  Immunology       Date:  2014-09       Impact factor: 7.397

5.  Ultrastructure of myoepithelial cells as a target cell in sialoadenitis of submandibular glands of lupus-prone female NZBxNZWF1 mice.

Authors:  Toshiharu Hayashi; Hideyuki Hayashi; Taeko Fujii; Chie Adachi; Keiko Hasegawa
Journal:  Virchows Arch       Date:  2008-06-19       Impact factor: 4.064

6.  Temporal changes in salivary glands of non-obese diabetic mice as a model for Sjögren's syndrome.

Authors:  N Roescher; B M Lodde; J L Vosters; P P Tak; M A Catalan; G G Illei; J A Chiorini
Journal:  Oral Dis       Date:  2011-09-14       Impact factor: 3.511

7.  Interleukin-17 and -22 synergy linking inflammation and EMT-dependent fibrosis in Sjögren's syndrome.

Authors:  M Sisto; L Lorusso; R Tamma; G Ingravallo; D Ribatti; S Lisi
Journal:  Clin Exp Immunol       Date:  2019-06-05       Impact factor: 4.330

8.  Salivary gland expression level of IκBα regulatory protein in Sjögren's syndrome.

Authors:  Margherita Sisto; Sabrina Lisi; Dario Domenico Lofrumento; Giuseppe Ingravallo; Raffaella De Lucro; Massimo D'Amore
Journal:  J Mol Histol       Date:  2013-02-03       Impact factor: 2.611

Review 9.  The role of epithelial cells in the pathogenesis of Sjögren's syndrome.

Authors:  Menelaos N Manoussakis; Efstathia K Kapsogeorgou
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

10.  X-linked ectodermal dysplasia receptor (XEDAR) gene silencing prevents caspase-3-mediated apoptosis in Sjögren's syndrome.

Authors:  Margherita Sisto; Loredana Lorusso; Sabrina Lisi
Journal:  Clin Exp Med       Date:  2015-12-11       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.